» Articles » PMID: 28869863

Understanding Molecular Interactions Between Scavenger Receptor A and Its Natural Product Inhibitors Through Molecular Modeling Studies

Overview
Date 2017 Sep 5
PMID 28869863
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Scavenger receptor A (SRA), as an immune regulator, has been shown to play important roles in lipid metabolism, cardiovascular diseases, and pathogen recognition. Several natural product inhibitors of SRA have been studied for their potential application in modulating SRA functions. To understand the binding mode of these inhibitors on SRA, we conducted systematic molecular modeling studies in order to identify putative binding domain(s) that may be responsible for their recognition to the receptor as well as their inhibitory activity. Treatment of SRA with one of the natural product inhibitors, rhein, led to significant dissociation of SRA oligomers to its trimer and dimer forms, which further supported our hypothesis on their putative mechanism of action. Such information is believed to shed light on design of more potent inhibitors for the receptor in order to develop potential therapeutics through immune system modulation.

Citing Articles

Malondialdehyde-Acetaldehyde Extracellular Matrix Protein Adducts Attenuate Unfolded Protein Response During Alcohol and Smoking-Induced Pancreatitis.

Bhatia R, Thompson C, Clement E, Ganguly K, Cox J, Rauth S Gastroenterology. 2022; 163(4):1064-1078.e10.

PMID: 35788346 PMC: 9796922. DOI: 10.1053/j.gastro.2022.06.071.


Complex Factors and Challenges that Affect the Pharmacology, Safety and Efficacy of Nanocarrier Drug Delivery Systems.

Piscatelli J, Ban J, Lucas A, Zamboni W Pharmaceutics. 2021; 13(1).

PMID: 33477395 PMC: 7830329. DOI: 10.3390/pharmaceutics13010114.

References
1.
Stephen S, Freestone K, Dunn S, Twigg M, Homer-Vanniasinkam S, Walker J . Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease. Int J Hypertens. 2010; 2010:646929. PMC: 2958427. DOI: 10.4061/2010/646929. View

2.
Yi H, Guo C, Yu X, Gao P, Qian J, Zuo D . Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity. Cancer Res. 2011; 71(21):6611-20. PMC: 3213980. DOI: 10.1158/0008-5472.CAN-11-1801. View

3.
Yi H, Yu X, Gao P, Wang Y, Baek S, Chen X . Pattern recognition scavenger receptor SRA/CD204 down-regulates Toll-like receptor 4 signaling-dependent CD8 T-cell activation. Blood. 2009; 113(23):5819-28. PMC: 2700321. DOI: 10.1182/blood-2008-11-190033. View

4.
Yu X, Yi H, Guo C, Zuo D, Wang Y, Kim H . Pattern recognition scavenger receptor CD204 attenuates Toll-like receptor 4-induced NF-kappaB activation by directly inhibiting ubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6. J Biol Chem. 2011; 286(21):18795-806. PMC: 3099696. DOI: 10.1074/jbc.M111.224345. View

5.
Jones G, Willett P, Glen R, Leach A, Taylor R . Development and validation of a genetic algorithm for flexible docking. J Mol Biol. 1997; 267(3):727-48. DOI: 10.1006/jmbi.1996.0897. View